. . . . . . . . . . . . . . . . . "cat(p(HGNC:TKT)) -| kin(p(PFH:\"PRKC Family\"))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "We have discovered that the lipid-soluble thiamine derivative benfotiamine can inhibit these three pathways (the hexosamine pathway, the advanced glycation end product (AGE) formation pathway and the diacylglycerol (DAG)-protein kinase C (PKC) pathway) as well as hyperglycemia-associated NF-kappaB activation, by activating the pentose phosphate pathway enzyme transketolase, which converts glyceraldehyde-3-phosphate and fructose-6-phosphate into pentose-5-phosphate" . . "Selventa" . . . . "2014-07-03T14:30:10.219+02:00"^^ . . .